Tag: natriuretic peptides

The aim of the study was to evaluate plasma natriuretic peptides (NPs): atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) concentrations in patients with paroxysmal, persistent and permanent atrial fibrillation (AF)...

Dilated cardiomyopathy (DCM) is a multifactorial heart disease in which there is enlargement and systolic dysfunction of one or both ventricles. The exhaustion of compensatory mechanisms leads to symptoms of congestive heart failure, which is a significant problem in contemporary cardiology. DCM is still diagnosed using clinical assessment; echocardiography is necessary, and in some clinical situations we need hemodynamic assessment in order to identify the etiology and progression of heart disease...

The purpose of the study was to assess whether preoperative and postoperative N-terminal fragments of B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) measurements could be used to identify patients at risk of early adverse cardiac events after carotid endarterectomy (CEA)...

W badaniach z ostatnich lat wykazano, że ocena peptydów natriuretycznych przeprowadzona u pacjentów z dusznością pozwala znacznie zwiększyć dokładność, z jaką może być wykluczone lub potwierdzone rozpoznanie niewydolności serca...

Effective treatment of chronic heart failure (CHF) has become a constant challenge for clinicians in the developed countries [1]. One of the therapeutic keystones in CHF, along with angiotensin-converting enzymes inhibitors (ACEI), is use of beta-blockers, which improves both left ventricular (LV) function and survival [2]. In recent years, increased attention has been focused on various circulating biologically active substances, collectively known as plasma biomarkers, and their utility in HF prognosis and therapy monitoring [3]...